<?xml version="1.0" encoding="iso-8859-1" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
 <channel>
 <atom:link href="http://rss.en.sourcews.com/cancer" rel="self" type="application/rss+xml"/>
  <title>Cancer - SOURCEWS WORLD - Inquire to the source</title> 
  <link>http://news.en.sourcews.com/cancer</link> 
  <description>Cancer - SOURCEWS WORLD - Inquire to the source</description> 
  <language>en</language> 
  <copyright>Copyright (c) SOURCEWS. All rights reserved</copyright> 
  <lastBuildDate>Tue, 02 Dec 2008 04:14:00 GMT</lastBuildDate> 
  <ttl>10</ttl> 
 <image>
  <title>Cancer - SOURCEWS WORLD - Inquire to the source</title> 
  <width>200</width> 
  <height>50</height> 
  <link>http://en.sourcews.com/</link>
  <url>http://en.sourcews.com/img/sc2_en.gif</url> 
  </image>
<item>
  <title>Wyeth and Progenics Announce Positive Outcome of Phase 3 Clinical Study of Subcutaneous Relistor for Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain</title> 
  <link>http://en.sourcews.com/wyeth-progenics-announce-positive</link>
	<guid>http://en.sourcews.com/wyeth-progenics-announce-positive</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Thu, 27 Nov 2008 03:22:00 GMT</pubDate> 
  </item>
<item>
  <title>Nation's leading experts to brief media on lung cancer treatment trends</title> 
  <link>http://en.sourcews.com/nation-leading-experts-brief-media-lung</link>
	<guid>http://en.sourcews.com/nation-leading-experts-brief-media-lung</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Tue, 25 Nov 2008 07:15:00 GMT</pubDate> 
  </item>
<item>
  <title>Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer</title> 
  <link>http://en.sourcews.com/avastin-commonly-used-chemotherapies</link>
	<guid>http://en.sourcews.com/avastin-commonly-used-chemotherapies</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Mon, 24 Nov 2008 10:23:00 GMT</pubDate> 
  </item>
<item>
  <title>Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer</title> 
  <link>http://en.sourcews.com/amgen-takeda-millennium-provide-update</link>
	<guid>http://en.sourcews.com/amgen-takeda-millennium-provide-update</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Sat, 22 Nov 2008 04:28:00 GMT</pubDate> 
  </item>
<item>
  <title>Tarceva brings new hope to patients with advanced non-small cell lung cancer</title> 
  <link>http://en.sourcews.com/tarceva-brings-new-hope-patients</link>
	<guid>http://en.sourcews.com/tarceva-brings-new-hope-patients</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Thu, 20 Nov 2008 16:39:00 GMT</pubDate> 
  </item>
<item>
  <title>Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer</title> 
  <link>http://en.sourcews.com/watson-announces-nda-month-formulation</link>
	<guid>http://en.sourcews.com/watson-announces-nda-month-formulation</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Thu, 20 Nov 2008 16:20:00 GMT</pubDate> 
  </item>
<item>
  <title>Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer</title> 
  <link>http://en.sourcews.com/ortho-biotech-announces-nda-submission</link>
	<guid>http://en.sourcews.com/ortho-biotech-announces-nda-submission</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Thu, 20 Nov 2008 15:49:00 GMT</pubDate> 
  </item>
<item>
  <title>Cervarix, GSK's cervical cancer vaccine, wins tender for Dutch national immunisation programme</title> 
  <link>http://en.sourcews.com/cervarix-gsk-cervical-cancer-vaccine_3</link>
	<guid>http://en.sourcews.com/cervarix-gsk-cervical-cancer-vaccine_3</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Thu, 20 Nov 2008 11:44:00 GMT</pubDate> 
  </item>
<item>
  <title>Phase III Studies Show That Vandetanib (ZACTIMA) Brings Clinical Benefits to Patients With Lung Cancer</title> 
  <link>http://en.sourcews.com/phase-iii-studies-show-that-vandetanib</link>
	<guid>http://en.sourcews.com/phase-iii-studies-show-that-vandetanib</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Wed, 19 Nov 2008 12:34:00 GMT</pubDate> 
  </item>
<item>
  <title>Eight International Cancer Projects</title> 
  <link>http://en.sourcews.com/eight-international-cancer-projects</link>
	<guid>http://en.sourcews.com/eight-international-cancer-projects</guid>
	<source url="http://rss.en.sourcews.com/cancer">Cancer - SOURCEWS WORLD - Inquire to the source</source> 
  <description></description> 
  <pubDate>Wed, 19 Nov 2008 05:07:00 GMT</pubDate> 
  </item>
</channel>
</rss>